In patients with type 2 diabetes starting insulin therapy for the first time, there was no difference in glycemic control or severe hypoglycemia between those using NPH insulin or more expensive analogs.
Medscape Medical News
Original Article: Human Insulin Could Be Front-Line for Many With Type 2 Diabetes